 |
|
Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
Ji Young Chang, Jae Hee Cheon
Precis Future Med. 2021;5(4):151-163. Published online 2021 Dec 27 DOI: https://doi.org/10.23838/pfm.2021.00128
|
|
Citations to this article as recorded by
 Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies
Cecelia Kelly, R. Balfour Sartor, John F. Rawls
American Journal of Physiology-Gastrointestinal and Liver Physiology.2025; 328(1): G17. CrossRef Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
Anna Pau, Ilaria Galliano, Elisa Barnini, Maddalena Dini, Antonio Pizzol, Alice Ponte, Stefano Gambarino, Pier Luigi Calvo, Massimiliano Bergallo
Medicina.2025; 61(1): 102. CrossRef Pharmacogenetics in personalized treatment in pediatric patients with inflammatory bowel disease (IBD)
Daniela Kosorínová, Pavlína Suchá, Zuzana Havlíčeková, Marek Pršo, Pavol Dvoran, Peter Bánovčin
Česko-slovenská pediatrie.2024; 79(4): 213. CrossRef
|